000640.KS
Dong-A Socio Holdings Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 94,000.00
+1.40%Year over year
Reported trailing growth
- Revenue
- +10.1%
- EBITDA
- +34.2%
- EBIT
- +15.8%
- EPS
- -8.8%
- Free cash flow
- +103.7%
- Operating cash flow
- +55.3%
Forward estimates
Based on analyst estimates
- Revenue
- -45.6%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +12.1%
- EBITDA
- +29.9%
- EBIT
- +37.2%
- Net income
- +101.3%
- EPS
- +99.3%
- Free cash flow
- +1975.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026